ARCHIVES

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

This article is from The Cancer Letter archive.

Vol. 27 No. 04 | January 26, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Would Add Money For Centers If Number Go Up, Greenwald Says; Five Options For Changes Listed

April 27, 1984

Commission Seeks Comparative Data on Cervical Cancer

August 16, 1991

NCI to Host SBIR Investor Forum

November 7, 2014

ACS Says 41 Percent Survive 5 Years

January 2, 1981

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005